Women cured of childhood leukaemia should be advised to have children while they are youngJuly 01, 2002Vienna, Austria: Women who have survived having leukaemia as children should receive fertility counselling because their reproductive life may be shortened even though they have an apparently normal menstrual cycle after treatment, according to Danish researchers. Dr Elisabeth Larsen, a research assistant from the Fertility Clinic at Copenhagen University Hospital, Denmark, has studied 26 long-term survivors of acute lymphoblastic leukaemia (ALL) and found that they tended to have smaller ovaries with fewer follicles (the group of cells containing the female egg) available in each menstrual cycle. However, the good news was that their ovaries appeared to be functioning normally in all other respects, she told the annual conference of the European Society of Human Reproduction and Embryology. She said: "Multi-agent chemotherapy has radically increased long-term survival of children with acute lymphoblastic leukaemia, but the treatment can induce late effects. It is well known that a proportion of the patients experience ovarian failure and infertility. The new finding is that female childhood cancer survivors with an apparently normal menstrual cycle might have a shortened reproductive span." Dr Larsen and her team took menstrual and pregnancy histories from 26 women* who had received standard chemotherapy for ALL contracted between the ages of six months and fourteen and a half years, and compared them with a control group of 20 women with no history of childhood cancer. Eight of the women in the ALL group had become pregnant naturally, resulting in 12 babies, one abortion and two ongoing pregnancies. One woman, aged 33, had tried to become pregnant without success for five years, but many of the women were young and 17 of the 26 had not even tried to conceive yet. All the women had regular menstrual cycles and normal hormonal levels, although the length of the cycle in the ALL group was significantly shorter than in the control group (28.9 versus 30.7 days). The researchers used transvaginal ultrasounds, taken at the beginning of the menstrual cycle, to measure the volume of the women's ovaries and to count the number of antral follicles (follicles that may mature and subsequently ovulate). They found that women in the ALL group had ovaries which were significantly smaller than the control group (12.3 ml in total volume compared with 13.7ml), and the total number of antral follicles per ovary was significantly lower in the ALL women, with an average of eight per ovary compared with 11 in the control group.
She said that it was not possible to give a precise estimate of how much shorter the women's reproductive life might be. "At present, in our hospital, we recommend to all female survivors of childhood cancer with normal ovarian function that they should try to have their first child before they are 30. However this recommendation is not made on the basis of any scientific findings. The majority of long-term survivors attend regular follow-up check-ups at our outpatient clinic and we are considering offering fertility counselling to them between the ages of 18 and 20. "The important message to come from this research is women who have survived ALL can become pregnant and have babies and they are doing so. However they should not postpone childbearing, and it might be that they should consider becoming mothers before pursuing a career," concluded Dr Larsen. (ends) | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. International study supports new standard of treatment for women with advanced ovarian cancer Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Plants display 'molecular amnesia' Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Dancing atoms now understood In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||